1,202
Views
2
CrossRef citations to date
0
Altmetric
Review Article

Infectious Mononucleosis: diagnosis and clinical interpretation

, , & ORCID Icon
Pages 107-116 | Received 25 Jan 2021, Accepted 11 Mar 2021, Published online: 14 Apr 2021

References

  • Sprunt TP, Evans FA. Mononuclear leucocytosis in reaction to acute infections (“infectious mononucleosis”). Bull Johns Hopkins Hosp. 1920;31:410–417.
  • Medović R, Igrutinović Z, Radojević-Marjanović R, et al. Clinical and laboratory differences between Epstein-Barr and cytomegalovirus infectious mononucleosis in children. Srp Arh Celok Lek. 2016;144:56–62.
  • Klemola E, Von Essen R, Henle G, et al. Infectious-mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies. J Infect Dis. 1970;121:608–614.
  • Hess RD. Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. J Clin Microbiol. 2004;42:3381–3387.
  • Taga K, Taga H, Tosato G. Diagnosis of atypical cases of infectious mononucleosis. Clinl Infect Dis. 2001;33:83–88.
  • Cunha BA, Chawla K. Fever of unknown origin (FUO): CMV infectious mononucleosis or lymphoma? Eur J Clin Microbiol Infect Dis. 2018;37:1373–1376.
  • Lennon P, Crotty M, Fenton JE. Infectious mononucleosis. Br Med J. 2015;350:h1825.
  • Ishii T, Sasaki Y, Maeda T, et al. Clinical differentiation of infectious mononucleosis that is caused by Epstein-Barr virus or cytomegalovirus: a single-center case-control study in Japan. J Infect Chemother. 2019;25:431–436.
  • Korsman SNJ, Van Zyl GU, Nutt L, et al. Epstein-Barr virus. In: Korsman SNJ, Van Zyl GU, Nutt L, et al., editors. Virology. Edinburgh: Churchill Livingstone; 2012. p. 58–59.
  • Hurt C, Tammaro D. Diagnostic evaluation of mononucleosis-like illnesses. Am J Med. 2007;120:911.e1-8.
  • Henle W, Henle GE, Horwitz CA. Epstein-barr virus specific diagnostic tests in infectous mononucleosis. Hum Pathol. 1974;5:551–565.
  • Burkitt D. A sarcoma involving the jaws in African children. Br J Surg. 1958;46:218–223.
  • Wright DH. Cytology and histochemistry of the Burkitt lymphoma. Br J Cancer. 1963;17:50–55.
  • Burkitt D, O’Conor GT. Malignant lymphoma in African children. I. A clinical syndrome. Cancer. 1961;14:258–269.
  • Burkitt D. A lymphoma syndrome in African children. Ann R Coll Surg Engl. 1962;30:211–219.
  • Epstein MA, Achong BG. Fine structural organization of human lymphoblasts of a tissue culture strain (EB1) from Burkitt’s Lymphoma. J Natl Cancer Inst. 1965;34:241–253.
  • Shubert S, Collee JG, Smith BJ. Infectious mononucleosis: a syndrome or a disease. Br Med J. 1954;1:671–675.
  • Chatterjee B, Deng Y, Holler A, et al. CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo. PLoS Pathog. 2019;15:e1007748–e.
  • Womack J, Jimenez M. Common questions about infectious mononucleosis. Am Fam Physician. 2015;91:372–376.
  • Kim WY, Montes-Mojarro IA, Fend F, et al. Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases. Front Pediatr. 2019;7:71.
  • Xie J-L, Zhang Y-L, Zhou X-G. Infectious mononucleosis caused by EBV infection with clonal cytotoxic T cells in an infant patient. Int J Clin Exp Pathol. 2017;10:9802–9807.
  • Baker CR, Kona S. Spontaneous splenic rupture in a patient with infectious mononucleosis. BMJ Case Rep. 2019;12:e230259.
  • Louppides S, Kakoullis L, Parpas G, et al. Upper eyelid oedema in a patient with pharyngitis/exudative tonsillitis and malaise: hoagland sign in infectious mononucleosis. BMJ Case Rep. 2019;12:e233719.
  • Dunmire SK, Verghese PS, Balfour HH Jr. Primary Epstein-Barr virus infection. J Clin Virol. 2018;102:84–92.
  • Thompson DF, Ramos CL. Antibiotic-induced rash in patients with infectious mononucleosis. Ann Pharmacother. 2017;51:154–162.
  • Chovel-Sella A, Ben Tov A, Lahav E, et al. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatrics. 2013;131:e1424–7.
  • Asgari MM, Begos DG. Spontaneous splenic rupture in infectious mononucleosis: a review. Yale J Biol Med. 1997;70:175–182.
  • Bartlett A, Williams R, Hilton M. Splenic rupture in infectious mononucleosis: a systematic review of published case reports. Injury. 2016;47:531–538.
  • Downey HAL, McKinlay CA. Acute lymphadenosis compared with acute lymphatic leukemia. Arch Internal Med. 1923;32:82–112.
  • García-Peris M, Jiménez Candel MI, Mañes Jiménez Y, et al. [Epstein-Barr virus primary infection in healthy children]. An Pediatr (Barc). 2019;90:376–385.
  • Macsween KF, Higgins CD, McAulay KA, et al. Infectious mononucleosis in University Students in the United Kingdom: evaluation of the clinical features and consequences of the disease. Clinl Infect Dis. 2010;50:699–706.
  • Ebell MH, Call M, Shinholser J, et al. Does This patient have infectious mononucleosis?: the rational clinical examination systematic review. Jama. 2016;315:1502–1509.
  • Tattevin P, Le Tulzo Y, Minjolle S, et al. Increasing incidence of severe Epstein-Barr virus-related infectious mononucleosis: surveillance study. J Clin Microbiol. 2006;44:1873–1874.
  • Auwaerter PG. Recent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control? Expert Rev Anti Infect Ther. 2006;4:1039–1049.
  • Paul JR, Bunnell WW. The presence of heterophile antibodies in infectious mononucleosis. Am J Med Sci. 1932;183:91–104.
  • Henle G, Henle W, Diehl V. Relation of Burkitt’s tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA. 1968;59:94–101.
  • Davison AJ, Eberle R, Ehlers B, et al. The order Herpesvirales. Arch Virol. 2009;154:171–177.
  • Cui J, Yan W, Xu S, et al. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: what we have found in the different patients. PLoS One. 2018;13:e0193171.
  • Duca KA, Shapiro M, Delgado-Eckert E, et al. A virtual look at Epstein-Barr virus infection: biological interpretations. PLoS Pathog. 2007;3:1388–1400.
  • Tsao SW, Tsang CM, Lo KW. Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B Biol Sci. 2017;372:1732.
  • Xu M, Zhang WL, Zhu Q, et al. Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies. Theranostics. 2019;9:1115–1124.
  • Cassaniti I, Cavagna L, Calarota SA, et al. Evaluation of EBV- and HCMV-specific T cell responses in Systemic Lupus Erythematosus (SLE) patients using a normalized enzyme-linked immunospot (ELISPOT) assay. J Immunol Res. 2019;2019:4236503.
  • Gross AJ, Hochberg D, Rand WM, et al. EBV and systemic lupus erythematosus: a new perspective. J Immunol. 2005;174:6599–6607.
  • Levin LI, Munger KL, O’Reilly EJ, et al. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol. 2010;67:824–830.
  • Handel AE, Williamson AJ, Disanto G, et al. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One. 2010;5:9.
  • Thorley-Lawson DA. EBV Persistence–Introducing the Virus. Curr Top Microbiol Immunol. 2015;390:151–209.
  • Beutel K, Gross-Wieltsch U, Wiesel T, et al. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin. Pediatr Blood Cancer. 2009;53:184–190.
  • Machón C, Fàbrega-Ferrer M, Zhou D, et al. Atomic structure of the Epstein-Barr virus portal. Nat Commun. 2019;10:3891.
  • Baer R, Bankier AT, Biggin MD, et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 1984;310:207–211.
  • Young LS, Yap LF, Murray PG. Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer. 2016;16:789–802.
  • Coleman CB, Lang J, Sweet LA, et al. Epstein-Barr Virus Type 2 infects T cells and induces B cell lymphomagenesis in humanized mice. J Virol. 2018;92:e00813–18.
  • Zanella L, Riquelme I, Buchegger K, et al. A reliable Epstein-Barr Virus classification based on phylogenomic and population analyses. Sci Rep. 2019;9:9829.
  • Sample J, Young L, Martin B, et al. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol. 1990;64:4084–4092.
  • Rickinson AB, Young LS, Rowe M. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol. 1987;61:1310–1317.
  • Hornsleth A, Siggaard-Andersen J, Hjort L. Epidemiology of herpesvirus and respiratory virus infections. Part 1. Serologic findings. Geriatrics 1975;30:61–68.
  • Sumaya CV, Henle W, Henle G, et al. Seroepidemiologic study of Epstein-Barr virus infections in a rural community. J Infect Dis. 1975;131:403–408.
  • Niederman JC. Infectious mononucleosis: observations on transmission. Yale J Biol Med. 1982;55:259–264.
  • Hallee TJ, Evans AS, Niederman JC, et al. Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years. Yale J Biol Med. 1974;47:182–195.
  • Infectious mononucleosis and its relationship to EB virus antibody. A joint investigation by university health physicians and P.H.L.S. laboratories. Br Med J. 1971;4:643–646.
  • Lennon P, Saunders J, Fenton JE. A longer stay for the kissing disease: epidemiology of bacterial tonsillitis and infectious mononucleosis over a 20-year period. J Laryngol Otol. 2013;127:187–191.
  • Dunmire SK, Hogquist KA, Balfour HH. Infectious Mononucleosis. Curr Top Microbiol Immunol. 2015;390:211–240.
  • Hoagland RJ. The incubation period of Infectious Mononucleosis. Am J Public Health Nations Health. 1964;54:1699–1705.
  • Fitzsimmons L, Kelly GL. EBV and apoptosis: the viral master regulator of cell fate? Viruses. 2017;9:339.
  • Laichalk LL, Hochberg D, Babcock GJ, et al. The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity. 2002;16:745–754.
  • Becker JA, Smith JA. Return to play after infectious mononucleosis. Sports Health. 2014;6:232–238.
  • Li C-W, Jheng B-R, Chen B-S. Investigating genetic-and-epigenetic networks, and the cellular mechanisms occurring in Epstein-Barr virus-infected human B lymphocytes via big data mining and genome-wide two-sided NGS data identification. PloS One. 2018;13:e0202537–e.
  • De Paschale M, Clerici P. Serological diagnosis of Epstein-Barr virus infection: problems and solutions. World J Virol. 2012;1:31–43.
  • Yetming KD, Lupey-Green LN, Biryukov S, et al. The BHLF1 Locus of Epstein-Barr virus contributes to viral latency and B-cell immortalization. J Virol. 2020;94:17.
  • Pich D, Mrozek-Gorska P, Bouvet M, et al. First days in the life of naive human B lymphocytes infected with Epstein-Barr virus. mBio. 2019;10:5.
  • Kenney SC, Mertz JE. Regulation of the latent-lytic switch in Epstein-Barr virus. Semin Cancer Biol. 2014;26:60–68.
  • Hadinoto V, Shapiro M, Sun CC, et al. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog. 2009;5:e1000496.
  • Tsurumi T, Fujita M, Kudoh A. Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol. 2005;15:3–15.
  • Van Der Meer W, Van Gelder W, De Keijzer R, et al. The divergent morphological classification of variant lymphocytes in blood smears. J Clin Pathol. 2007;60:838–839.
  • Seitanidis B. A comparison of the Monospot with the Paul-Bunnell test in infectious mononucleosis and other diseases. J Clin Pathol. 1969;22:321–323.
  • Basson V, Sharp AA. Monospot: a differential slide test for infectious mononucleosis. J Clin Pathol. 1969;22:324–325.
  • Burgio GR, Monafo V. Infectious mononucleosis fifty years after the discovery of the Paul-Bunnell test. Infection. 1983;11:1–5.
  • Stokoe IH. Atypical mononucleosis and glandular fever. J R Coll Gen Pract. 1969;17:340–350.
  • Hess RD. Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. J Clin Microbiol. 2004;42:3381.
  • Crowley A, Connell J, Schaffer K, et al. Is there diagnostic value in detection of immunoglobulin g antibodies to the Epstein-Barr virus early antigen? Biores Open Access. 2012;1:291–296.
  • Tembhare P, Ramani M, Syed K, et al. Immunophenotypic profile in acute infectious mononucleosis mimicking malignant lymphoproliferative disorder: a case report and review of literature. Indian J Haem Blood Trans. 2010;26:118–121.
  • Scherrenburg J, Piriou ERWAN, Nanlohy NM, et al. Detailed analysis of Epstein-Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis. Clin Exp Immunol. 2008;153:231–239.
  • Fugl A, Andersen CL. Epstein-Barr virus and its association with disease - a review of relevance to general practice. BMC Fam Pract. 2019;20:62.
  • Petrova M, Muhtarova M, Nikolova M, et al. Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients. World J Gastroenterol. 2006;12:5711–5716.
  • Kang M-J, Kim T-H, Shim K-N, et al. Infectious mononucleosis hepatitis in young adults: two case reports. Korean J Intern Med. 2009;24:381–387.
  • Herold J, Grimaldo F. Epstein-Barr virus-induced jaundice. Clin Pract Cases Emerg Med. 2020;4:69–71.
  • Kofteridis DP, Koulentaki M, Valachis A, et al. Epstein Barr virus hepatitis. Eur J Intern Med. 2011;22:73–76.
  • Davison AJ. Herpesvirus systematics. Vet Microbiol. 2010;143:52–69.
  • Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet. 1964;1:702–703.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.